180 related articles for article (PubMed ID: 20850565)
1. Trigger-specific risk factors and response to therapy in long QT syndrome type 2.
Kim JA; Lopes CM; Moss AJ; McNitt S; Barsheshet A; Robinson JL; Zareba W; Ackerman MJ; Kaufman ES; Towbin JA; Vincent M; Goldenberg I
Heart Rhythm; 2010 Dec; 7(12):1797-805. PubMed ID: 20850565
[TBL] [Abstract][Full Text] [Related]
2. Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome.
Goldenberg I; Thottathil P; Lopes CM; Moss AJ; McNitt S; O-Uchi J; Robinson JL; Zareba W; Ackerman MJ; Kaufman ES; Towbin JA; Vincent M; Barsheshet A
Heart Rhythm; 2012 Jan; 9(1):49-56. PubMed ID: 21871251
[TBL] [Abstract][Full Text] [Related]
3. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.
Migdalovich D; Moss AJ; Lopes CM; Costa J; Ouellet G; Barsheshet A; McNitt S; Polonsky S; Robinson JL; Zareba W; Ackerman MJ; Benhorin J; Kaufman ES; Platonov PG; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Goldenberg I
Heart Rhythm; 2011 Oct; 8(10):1537-43. PubMed ID: 21440677
[TBL] [Abstract][Full Text] [Related]
4. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
[TBL] [Abstract][Full Text] [Related]
5. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
[TBL] [Abstract][Full Text] [Related]
6. Syncope in genotype-negative long QT syndrome family members.
Olde Nordkamp LR; Ruwald MH; Goldenberg I; Wieling W; McNitt S; Polonsky B; Wilde AA; van Dijk N; Moss AJ
Am J Cardiol; 2014 Oct; 114(8):1223-8. PubMed ID: 25173441
[TBL] [Abstract][Full Text] [Related]
7. Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type.
Platonov PG; McNitt S; Polonsky B; Rosero SZ; Kutyifa V; Huang A; Moss AJ; Zareba W
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e005918. PubMed ID: 30012873
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome.
Ali RH; Zareba W; Moss AJ; Schwartz PJ; Benhorin J; Vincent GM; Locati EH; Priori S; Napolitano C; Towbin JA; Hall WJ; Robinson JL; Andrews ML; Zhang L; Timothy K; Medina A
Am J Cardiol; 2000 Feb; 85(4):457-61. PubMed ID: 10728950
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
Schwartz PJ; Priori SG; Spazzolini C; Moss AJ; Vincent GM; Napolitano C; Denjoy I; Guicheney P; Breithardt G; Keating MT; Towbin JA; Beggs AH; Brink P; Wilde AA; Toivonen L; Zareba W; Robinson JL; Timothy KW; Corfield V; Wattanasirichaigoon D; Corbett C; Haverkamp W; Schulze-Bahr E; Lehmann MH; Schwartz K; Coumel P; Bloise R
Circulation; 2001 Jan; 103(1):89-95. PubMed ID: 11136691
[TBL] [Abstract][Full Text] [Related]
12. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD
Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
[TBL] [Abstract][Full Text] [Related]
14. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
[TBL] [Abstract][Full Text] [Related]
15. Effect of change in posture and exercise on repolarization in patients with long QT syndrome with HERG channel mutations.
Walker BD; Krahn AD; Klein GJ; Skanes AC; Yee R; Wang J; Hegele RA
Can J Cardiol; 2005 Jan; 21(1):33-8. PubMed ID: 15685300
[TBL] [Abstract][Full Text] [Related]
16. Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome.
Younis A; Bos JM; Zareba W; Aktas MK; Wilde AAM; Tabaja C; Bodurian C; Tobert KE; McNitt S; Polonsky B; Shimizu W; Ackerman MJ; Goldenberg I
JAMA Cardiol; 2023 Aug; 8(8):775-783. PubMed ID: 37436769
[TBL] [Abstract][Full Text] [Related]
17. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.
Priori SG; Napolitano C; Schwartz PJ; Grillo M; Bloise R; Ronchetti E; Moncalvo C; Tulipani C; Veia A; Bottelli G; Nastoli J
JAMA; 2004 Sep; 292(11):1341-4. PubMed ID: 15367556
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.
Wang M; Szepietowska B; Polonsky B; McNitt S; Moss AJ; Zareba W; Auerbach DS
Am J Cardiol; 2018 Jan; 121(2):182-187. PubMed ID: 29174490
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome.
Goldenberg I; Moss AJ; Peterson DR; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Priori SG; Qi M; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
Circulation; 2008 Apr; 117(17):2184-91. PubMed ID: 18427136
[TBL] [Abstract][Full Text] [Related]
20. Long QT syndrome in adults.
Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
